|  | Angiographic restenosis |  |  |  |  |  |
---|---|---|---|---|---|---|---|
Study/Procedure | n | rate (%) | Death (%) | MI (%) | CABG (%) | PTCA (%) | MACE (%) |
 |  |  |  |  |  |  | |
   Stent | 259 | 22* | 1.2 | 3.5 | 6.9 | 10.0* | 23.2* |
   PTCA | 257 | 32 | 0.8 | 1.9 | 5.1 | 20.6 | 31.5 |
 |  |  |  |  |  |  | |
   Stent | 205 | 32* | 1.5 | 3.4 | 5.8 | 15.1 | 21.0 |
   PTCA | 202 | 42 | 2.0 | 3.5 | 8.9 | 16.4 | 26.2 |
BENESTENT II [35] | Â | Â | Â | Â | Â | Â | Â |
   Stent (heparin coated) | 413 | 16* | 1.0 | 1.9 | 1.9 | 9.4* | 15.7* |
   PTCA | 410 | 31 | 1.0 | 1.5 | 1.5 | 15.6 | 22.4 |
EPISTENT [11] | Â | Â | Â | Â | Â | Â | Â |
   Stent + abciximab | 794 | 31†| 1.0 | 4.4 | 5.8 | 13.6* | 18.6* |
   PTCA + abciximab | 796 | 40 | 2.1 | 6.4 | 6.3 | 18.3 | 24.9 |
ARTS [39] | Â | Â | Â | Â | Â | Â | Â |
   Stent | 600 | N/A | 2.5 | 5.3 | 4.7* | 12.2* | 26.3* |
   CABG | 605 | N/A | 2.8 | 4.0 | 0.5 | 3.0 | 12.2 |